Crystal structures of HIV-1 reverse transcriptase mutated at codons 100, 106 and 108 show nevirapine resistance is mediated via perturbation of interactions with Tyr181 or Tyr188

Crystal structures of HIV-1 reverse transcriptase mutated at codons 100, 106 and 108 show nevirapine resistance is mediated via perturbation of interactions with Tyr181 or Tyr188

Bibliographic Details
Main Authors:	Stammers, D, Ren, J, Nichols, C, Chamberlain, P, Weaver, K, Short, SA, Stuart, D
Format:	Journal article
Published:	2002

Similar Items

Crystal structures of HIV-1 reverse transcriptases mutated at codons 100, 106 and 108 and mechanisms of resistance to non-nucleoside inhibitors.
by: Ren, J, et al.
Published: (2004)

Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors.
by: Ren, J, et al.
Published: (2001)

Relationship of potency and resilience to drug resistant mutations for GW420867X revealed by crystal structures of inhibitor complexes for wild-type, Leu100Ile, Lys101Glu, and Tyr188Cys mutant HIV-1 reverse transcriptases.
by: Ren, J, et al.
Published: (2007)

Mutational analysis of Tyr-318 within the non-nucleoside reverse transcriptase inhibitor binding pocket of human immunodeficiency virus type I reverse transcriptase.
by: Pelemans, H, et al.
Published: (1998)

Structural insights into mechanisms of non-nucleoside drug resistance for HIV-1 reverse transcriptases mutated at codons 101 or 138.
by: Ren, J, et al.
Published: (2006)

Identification of Tyr58 as the proton donor in the aspartate-alpha-decarboxylase reaction.
by: Saldanha, SA, et al.
Published: (2001)

Identification of Tyr58 as the proton donor in the aspartate-alpha-decarboxylase reaction.
by: Saldanha, SA, et al.
Published: (2001)

Functional effects of the p.Asp188Tyr mutation in the Geranylgeranyl Diphosphate Synthase (GGPS1) gene associated with bisphosphonate-related atypical femoral fractures
by: Roca-Ayats, N, et al.
Published: (2017)

Crystal structures of Zidovudine- or Lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215.
by: Chamberlain, P, et al.
Published: (2002)

Ligand induced activation of human TRPM2 requires the terminal ribose of ADPR and involves Arg 1433 and Tyr 1349
by: Fliegert, R, et al.
Published: (2017)

Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
by: Ur, E, et al.
Published: (1993)

Mutations at amino acid positions 63, 189, and 396 of human immunodeficiency virus type 1 reverse transcriptase (RT) partially restore the DNA polymerase activity of a Trp229Tyr mutant RT.
by: Pelemans, H, et al.
Published: (2001)

Functional Role of Tyr12 in the Catalytic Activity of Novel Zeta-like Glutathione S-transferase from Acidovorax sp. KKS102
by: Shehu, Dayyabu, et al.
Published: (2018)

A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
by: Bomanji, J, et al.
Published: (1992)

Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype
by: Adams, P, et al.
Published: (2018)

Mutagenesis of human DNA polymerase lambda: essential roles of Tyr505 and Phe506 for both DNA polymerase and terminal transferase activities.
by: Shevelev, I, et al.
Published: (2003)

OPTICALLY DETECTED MAGNETIC-FIELD EFFECTS ON REACTION CENTERS OF RHODOBACTER-SPHAEROIDES-2.4.1 AND ITS TYR M210-]TRP MUTANT
by: Vandervos, R, et al.
Published: (1995)

Abolishment of the Tyr-15 inhibitory phosphorylation site on cdc2 reduces the radiation-induced G(2) delay, revealing a potential checkpoint in early mitosis.
by: Fletcher, L, et al.
Published: (2002)

Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase.
by: Ren, J, et al.
Published: (2000)

Cloning, expression, purification, and crystallisation of HIV-2 reverse transcriptase.
by: Bird, L, et al.
Published: (2003)

A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance.
by: Larder, B, et al.
Published: (1999)

Structural basis for the improved drug resistance profile of new generation benzophenone non-nucleoside HIV-1 reverse transcriptase inhibitors.
by: Ren, J, et al.
Published: (2008)

Serological analysis of antigen-specific helper factors specific for poly-L(Tyr, Glu)-poly-DLAla--poly-LLys [(T, G)-A--L] and L Glu60-LAla30-LTyr10 (GAT).
by: Howie, S, et al.
Published: (1979)

Mice with an N-ethyl-N-nitrosourea (ENU) induced Tyr209Asn mutation in natriuretic peptide receptor 3 (NPR3) provide a model for kyphosis associated with activation of the MAPK signaling pathway
by: Esapa, C, et al.
Published: (2016)

Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors.
by: Ren, J, et al.
Published: (2002)

Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase.
by: Ren, J, et al.
Published: (2008)

HIV reverse transcriptase structures: designing new inhibitors and understanding mechanisms of drug resistance.
by: Ren, J, et al.
Published: (2005)

PENGGUNAAN SepPaks ALUMINA SEBAGAI ALAT UJI KUALIT AS SISTEM GEL GENERATOR TUNGSTEN-188/RENIUM-188 (The Use of Alumina SepPaks As A Quality Control Toolfor The Tungsten188/ Rhenium-188 Gel Generators System)
by: Perpustakaan UGM, i-lib
Published: (2012)

Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine.
by: Lennerstrand, J, et al.
Published: (2001)

Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors.
by: Esnouf, R, et al.
Published: (1995)

2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1.
by: Chan, J, et al.
Published: (2001)

Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding.
by: Ren, J, et al.
Published: (2000)

A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistance.
by: Harrigan, P, et al.
Published: (2002)

Crystal structures of HIV-1 reverse transcriptase in complex with carboxanilide derivatives.
by: Ren, J, et al.
Published: (1998)

JTW 108 - Makroekonomi
by: PPPJJ, Pusat Pengajian Pendidikan Jarak Jauh
Published: (2003)

STRUCTURAL STUDIES ON HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
by: Stammers, D, et al.
Published: (1990)

Intrapartum single-dose carbamazepine reduces nevirapine levels faster and may decrease resistance after a single dose of nevirapine for perinatal HIV prevention.
by: Muro, E, et al.
Published: (2012)

Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.
by: Herzmann, C, et al.
Published: (2004)

Inhibition of HIV-1 reverse transcriptase by defined template/primer DNA oligonucleotides: effect of template length and binding characteristics.
by: Idriss, H, et al.
Published: (1994)

Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2.
by: Freeman, G, et al.
Published: (2004)